{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:49:11Z","timestamp":1777495751443,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007479","name":"Fondazione Cariparo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007479","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CIB"},{"name":"UE THALAMOSS Project","award":["306201-FP7-HEALTH-2012-INNOVATION-1"],"award-info":[{"award-number":["306201-FP7-HEALTH-2012-INNOVATION-1"]}]},{"name":"Telethon","award":["GGP10124"],"award-info":[{"award-number":["GGP10124"]}]},{"name":"COFIN-2010"},{"name":"Associazione Veneta per la Lotta alla Talassemia"},{"name":"AIRC-2012"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.ejphar.2015.02.018","type":"journal-article","created":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T07:33:22Z","timestamp":1424331202000},"page":"84-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Erythroid differentiation ability of butyric acid analogues: Identification of basal chemical structures of new inducers of foetal haemoglobin"],"prefix":"10.1016","volume":"752","author":[{"given":"Nicoletta","family":"Bianchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano","family":"Chiarabelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Zuccato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Lampronti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Borgatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Amari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Delcanale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Chiavilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Prus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eitan","family":"Fibach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Gambari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2015.02.018_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1477-7525-4-59","article-title":"Hydroxyurea and sickle cell anemia: effect on quality of life","volume":"4","author":"Ballas","year":"2006","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.ejphar.2015.02.018_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejps.2012.05.017","article-title":"A multifunctional 5-aminolevulinic acid derivative induces erythroid differentiation of K562 human erythroleukemic cells","volume":"47","author":"Berkovitch-Luria","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2015.02.018_bib3","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1182\/blood-2008-09-171728","article-title":"Short-chain fatty acid-mediated effects on erythropoiesis in primary definitive erythroid cells","volume":"113","author":"Bhatia","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.02.018_bib4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1046\/j.1365-2141.2001.02843.x","article-title":"Accumulation of gamma-globin mRNA and induction of erythroid differentiation after treatment of human leukaemic K562 cells with tallimustine","volume":"113","author":"Bianchi","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1182\/blood.V81.2.529.529","article-title":"Fetal hemoglobin induction with butyric acid: efficacy and toxicity","volume":"81","author":"Blau","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.02.018_bib6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1006\/bcmd.1997.0162","article-title":"Abrogation of IL-3 requirements and stimulation of hematopoietic cell proliferation in vitro and in vivo by carboxylic acids","volume":"23","author":"Boosalis","year":"1997","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ejphar.2015.02.018_bib7","first-page":"979","article-title":"On the formation of a peculiar benzidine-positive band in incubation in vitro of different hemoglobins with various plasmas","volume":"39","author":"Bottini","year":"1963","journal-title":"Boll. Soc. Ital. Biol. Sper."},{"key":"10.1016\/j.ejphar.2015.02.018_bib8","first-page":"1","article-title":"Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy","volume":"8","author":"Breymann","year":"1999","journal-title":"J. Matern. Fetal Med."},{"key":"10.1016\/j.ejphar.2015.02.018_bib9","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis and treatment of sickle cell disease","volume":"337","author":"Bunn","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2015.02.018_bib10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/0026-0495(83)90134-8","article-title":"The effects of cyclopropane carboxylic acid on hepatic pyruvate metabolism","volume":"32","author":"Buxton","year":"1983","journal-title":"Metab. Clin. Exp."},{"issue":"1","key":"10.1016\/j.ejphar.2015.02.018_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0092-8674(78)90305-7","article-title":"Sodium butyrate inhibits histone deacetylation in cultured cells","volume":"14","author":"Candido","year":"1978","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2015.02.018_bib12","first-page":"237","article-title":"Differential expression of the globin genes in human leukemia K562(S) cells induced to differentiate by hemin or butyric acid","volume":"41","author":"Cioe","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2015.02.018_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood.V85.1.43.bloodjournal85143","article-title":"Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial","volume":"85","author":"Collins","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.02.018_bib14","first-page":"351","article-title":"Butyrate stimulates HbF in adult baboons","volume":"316B","author":"Constantoulakis","year":"1989","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.ejphar.2015.02.018_bib15","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood.V74.6.1963.1963","article-title":"On the induction of fetal hemoglobin by butyrates: in vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-AzaC and AraC","volume":"74","author":"Constantoulakis","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.02.018_bib16","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood.V72.6.1961.1961","article-title":"alpha-Amino-N-butyric acid stimulates fetal hemoglobin in the adult","volume":"72","author":"Constantoulakis","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.02.018_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/bcmd.2000.0283","article-title":"Oral isobutyramide therapy in patients with thalassemia intermedia: results of a phase II open study","volume":"26","author":"Domenica Cappellini","year":"2000","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ejphar.2015.02.018_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood.V84.1.339.339","article-title":"Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate","volume":"84","author":"Dover","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.02.018_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00062752-199502020-00002","article-title":"Butyrate in the treatment of sickle cell disease and [beta]-thalassemia","volume":"2","author":"Faller","year":"1995","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/asheducation-2006.1.58","article-title":"Induction of fetal hemoglobin in the treatment of sickle cell disease","author":"Fathallah","year":"2006","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.ejphar.2015.02.018_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bcmd.2009.02.006","article-title":"Differences in response to fetal hemoglobin induction therapy in beta-thalassemia and sickle cell disease","volume":"43","author":"Fathallah","year":"2009","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ejphar.2015.02.018_bib22","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1182\/blood.V88.6.1960.bloodjournal8861960","article-title":"Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial","volume":"88","author":"Ferster","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.02.018_bib23","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood-2002-10-3096","article-title":"Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells","volume":"102","author":"Fibach","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.02.018_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1600-0609.2006.00731.x","article-title":"Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients","volume":"77","author":"Fibach","year":"2006","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib25","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1182\/blood.V82.7.2203.2203","article-title":"Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and beta-thalassemia","volume":"82","author":"Fibach","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.02.018_bib26","first-page":"974","article-title":"Resveratrol: antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and \u03b2-thalassemia patients","volume":"29","author":"Fibach","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2015.02.018_bib27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bjh.12304","article-title":"A randomized phase I\/II trial of HQK-1001, an oral fetal globin gene inducer, in \u03b2-thalassaemia intermedia and HbE\/\u03b2-thalassaemia","volume":"161","author":"Fucharoen","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib28","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1182\/blood.V95.11.3555","article-title":"Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units: kit ligand induces a dose-dependent fetal hemoglobin reactivation potentiated by sodium butyrate","volume":"95","author":"Gabbianelli","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.02.018_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2141.1979.tb05850.x","article-title":"The importance of the genetic picture and globin synthesis in determining the clinical and haematological features of thalassaemia intermedia","volume":"41","author":"Gallo","year":"1979","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib30","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1128\/MCB.11.9.4690","article-title":"5\u2032-flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells","volume":"11","author":"Glauber","year":"1991","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.ejphar.2015.02.018_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/092986707779313318","article-title":"Medicinal chemistry of fetal hemoglobin inducers for treatment of beta-thalassemia","volume":"14","author":"Gambari","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2015.02.018_bib32","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/scd.2008.0235","article-title":"Valproic acid increases CXCR4 expression in hematopoietic stem\/progenitor cells by chromatin remodeling","volume":"18","author":"Gul","year":"2009","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.ejphar.2015.02.018_bib33","unstructured":"Hayhurst, W., Allen, L., Girondi, P.L. Patent EP0627220A1; 1994."},{"key":"10.1016\/j.ejphar.2015.02.018_bib34","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1073\/pnas.88.16.7276","article-title":"Detection of specific polymerase chain reaction product by utilizing the 5\u2032\u20133\u2032 exonuclease activity of Thermus aquaticus DNA polymerase","volume":"88","author":"Holland","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2015.02.018_bib35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ajh.2830060210","article-title":"Sickle cell anemia as a syndrome: a review of diagnostic features","volume":"6","author":"Huisman","year":"1979","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib36","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/bjh.12635","article-title":"A phase 2 study of HQK-1001, an oral fetal haemoglobin inducer, in \u03b2-thalassaemia intermedia","volume":"3","author":"Inati","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4103\/0971-6866.116128","article-title":"Comparison of in-vitro and in-vivo response to fetal hemoglobin production and \u03b3-mRNA expression by hydroxyurea in Hemoglobinopathies","volume":"19","author":"Italia","year":"2013","journal-title":"Indian J. Hum. Genet."},{"key":"10.1016\/j.ejphar.2015.02.018_bib38","first-page":"229","article-title":"Fetal hemoglobin induction by the histone deacetylase inhibitor, scriptaid","volume":"51","author":"Johnson","year":"2005","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib39","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1007\/s11033-011-1253-9","article-title":"Contribution of \u03b2-globin cluster polymorphisms to raise fetal hemoglobin levels in normal adults","volume":"39","author":"Jouini","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejphar.2015.02.018_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.8755-8920.2003.00119.x","article-title":"Expression of IL-4, IL-8 and IL-18 messenger RNAs in maternal peripheral blood and relationships with the HbF-gamma chain mRNA in it","volume":"51","author":"Kato","year":"2004","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib41","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/ajh.23306","article-title":"A phase 1\/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease","volume":"87","author":"Kutlar","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib42","doi-asserted-by":"crossref","first-page":"E255","DOI":"10.1002\/ajh.23533","article-title":"A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease","volume":"88","author":"Kutlar","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1034\/j.1600-0609.2003.00113.x","article-title":"Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin","volume":"71","author":"Lampronti","year":"2003","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajh.2830420118","article-title":"Fetal hemoglobin reactivation in baboon and man: a short perspective","volume":"42","author":"Lavelle","year":"1993","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome","volume":"45","author":"Lozzio","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.02.018_bib46","first-page":"700","article-title":"Valproic acid, trichostatin and their combination with hemin preferentially enhance gamma-globin gene expression in human erythroid liquid cultures","volume":"86","author":"Marianna","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.ejphar.2015.02.018_bib47","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1182\/blood.V90.5.2075","article-title":"Induction of gamma-globin by histone deacetylase inhibitors","volume":"90","author":"McCaffrey","year":"1997","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ejphar.2015.02.018_bib48","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2010.08395.x","article-title":"A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcers","volume":"151","author":"McMahon","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/jir.1990.10.357","article-title":"Interferon-gamma modulates fetal hemoglobin synthesis in sickle cell anemia and thalassemia","volume":"10","author":"Miller","year":"1990","journal-title":"J. Interferon Res."},{"key":"10.1016\/j.ejphar.2015.02.018_bib50","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2141.2004.05083.x","article-title":"Rapamycin-mediated induction of gamma-globin mRNA accumulation in human erythroid cells","volume":"126","author":"Mischiati","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib51","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1074\/jbc.M110.115725","article-title":"Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cells","volume":"286","author":"Muralidhar","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2015.02.018_bib52","first-page":"62","article-title":"Genetically based states of elevated quantity of foetal haemoglobin (Hb F) in healthy individuals and patients","volume":"30","author":"Musielak","year":"2011","journal-title":"Pol. Merkur. Lekarski"},{"key":"10.1016\/j.ejphar.2015.02.018_bib53","unstructured":"Newmark, H.L. U.S. Patent 5645852A; 1989."},{"issue":"1","key":"10.1016\/j.ejphar.2015.02.018_bib54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0223-5234(00)01199-5","volume":"36","author":"Nudelman","year":"2001","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2015.02.018_bib55","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood.V88.3.1079.1079","article-title":"In vivo search for butyrate responsive sequences using transgenic mice carrying A gamma gene promoter mutants","volume":"88","author":"Pace","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.02.018_bib56","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/j.1460-2075.1984.tb02210.x","article-title":"Human globin gene transcription in injected Xenopus oocytes: enhancement by sodium butyrate","volume":"3","author":"Partington","year":"1984","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2015.02.018_bib57","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/03630260701680367","article-title":"Pharmacogenomics and therapeutics of hemoglobinopathies","volume":"32","author":"Patrinos","year":"2008","journal-title":"Hemoglobin"},{"key":"10.1016\/j.ejphar.2015.02.018_bib58","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1182\/blood-2013-11-538470","article-title":"A phase 2 trial of HQK-1001 in HbE-\u03b2 thalassemia demonstrates HbF induction and reduced anemia","volume":"123","author":"Patthamalai","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.02.018_bib59","unstructured":"Perrine, S. U.S. Patent 4822821A; 1989."},{"key":"10.1016\/j.ejphar.2015.02.018_bib60","unstructured":"Perrine, S.P., Faller, D.V., Berenson, R.J. U.S. Patent 8618068; 2013."},{"issue":"1","key":"10.1016\/j.ejphar.2015.02.018_bib61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/blood.V74.1.454.454","article-title":"Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia","volume":"74","author":"Perrine","year":"1989","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ejphar.2015.02.018_bib62","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.hoc.2013.11.009","article-title":"Targeted fetal hemoglobin induction for treatment of beta hemoglobinopathies","volume":"28","author":"Perrine","year":"2014","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.ejphar.2015.02.018_bib63","doi-asserted-by":"crossref","first-page":"8540","DOI":"10.1073\/pnas.85.22.8540","article-title":"Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching","volume":"85","author":"Perrine","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2015.02.018_bib64","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1177\/0091270010379810","article-title":"Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers","volume":"51","author":"Perrine","year":"2011","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib65","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2015.02.018_bib66","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1034\/j.1600-0609.2000.90032.x","article-title":"Two-phase liquid culture system models normal human adult erythropoiesis at the molecular level","volume":"64","author":"Pope","year":"2000","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib67","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jcp.1040850305","article-title":"Differentiation of erythroleukemic cells in vitro: irreversible induction by dimethyl sulfoxide (DMSO)","volume":"85","author":"Preisler","year":"1975","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib68","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0145-2126(96)00132-4","article-title":"The human bladder carcinoma cell line 5637 constitutively secretes functional cytokines","volume":"21","author":"Quentmeier","year":"1997","journal-title":"Leuk. Res."},{"issue":"3\u20134","key":"10.1016\/j.ejphar.2015.02.018_bib69","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/1098-2299(200007\/08)50:3\/4<379::AID-DDR20>3.0.CO;2-8","article-title":"Prodrugs of butyric acid from bench to bedside: synthetic design, mechanisms of action, and clinical applications","volume":"50","author":"Raphaeli","year":"2000","journal-title":"Drug Dev. Res."},{"issue":"7","key":"10.1016\/j.ejphar.2015.02.018_bib70","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ajh.23725","article-title":"A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease","volume":"89","author":"Reid","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib71","first-page":"791","article-title":"Post-transcriptional effects of interleukin-3, interferon-gamma, erythropoietin and butyrate on in vitro hemoglobin chain synthesis in congenital hemolytic anemia","volume":"86","author":"Reinhardt","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.ejphar.2015.02.018_bib72","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1182\/blood.V84.11.3929.bloodjournal84113929","article-title":"Augmentation of gamma-globin gene promoter activity by carboxylic acids and components of the human beta-globin locus control region","volume":"84","author":"Safaya","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.02.018_bib73","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ajh.21539","article-title":"Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients","volume":"84","author":"Salvatori","year":"2009","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib74","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJM199506153322404","article-title":"Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies","volume":"332","author":"Sher","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2015.02.018_bib75","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V95.3.863.003k12_863_869","article-title":"Quantitative PCR analysis of HbF inducers in primary human adult erythroid cells","volume":"95","author":"Smith","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2015.02.018_bib76","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1146\/annurev.me.43.020192.002433","article-title":"Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies","volume":"43","author":"Stamatoyannopoulos","year":"1992","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejphar.2015.02.018_bib77","first-page":"95","article-title":"Therapies to increase fetal hemoglobin in sickle cell disease","volume":"2","author":"Steinberg","year":"2003","journal-title":"Curr. Hematol. Rep."},{"key":"10.1016\/j.ejphar.2015.02.018_bib78","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0003-9861(85)90775-1","article-title":"The effects of cyclopropane carboxylate on hepatic pyruvate metabolism","volume":"243","author":"Steinhelper","year":"1985","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2015.02.018_bib79","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/excr.2002.5632","article-title":"Human CD34+ hematopoietic progenitor cells hyperacetylate core histones in response to sodium butyrate, but not trichostatin A","volume":"280","author":"Travers","year":"2002","journal-title":"Exp. Cell Res."},{"issue":"Pt 1","key":"10.1016\/j.ejphar.2015.02.018_bib80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1242\/jcs.99.1.13","article-title":"Histone acetylation and control of gene expression","volume":"99","author":"Turner","year":"1991","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2015.02.018_bib81","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/scel.1995.0031","article-title":"Histone acetylation in chromatin and chromosomes","volume":"6","author":"Turner","year":"1995","journal-title":"Semin. Cell Biol."},{"key":"10.1016\/j.ejphar.2015.02.018_bib82","doi-asserted-by":"crossref","unstructured":"Voss, J.W., Caron, C.U.S. Patent 5,700,640; 1997.","DOI":"10.1016\/S0899-9007(97)83020-1"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915001132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915001132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T05:20:12Z","timestamp":1651296012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915001132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":82,"alternative-id":["S0014299915001132"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.02.018","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythroid differentiation ability of butyric acid analogues: Identification of basal chemical structures of new inducers of foetal haemoglobin","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}